News
Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic antibodiesLong-term outcomes and survival data for Ziihera® (zanidatamab-hrii), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback